查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球腦機介面市場：按組件、按產品類型、按技術、按應用、按最終用戶、按地區 - 預測到 2029 年
市場調查報告書
商品編碼
1482052

全球腦機介面市場：按組件、按產品類型、按技術、按應用、按最終用戶、按地區 - 預測到 2029 年

Brain Computer Interface Market by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 242 Pages | 訂單完成後即時交付

價格
簡介目錄

腦機介面領域預計將從 2024 年的 2.62 億美元增加到 2029 年的 5.06 億美元，預測期內複合年成長率為 14.1%。

神經系統疾病發生率和盛行率的上升、對非侵入性和穿戴式式腦機介面設備的需求不斷增加、研發投資的增加等是推動該市場成長的因素。另一方面，在預測期內，嚴格的監管要求和與BCI系統相關的高成本可能會在一定程度上阻礙腦機介面解決方案的採用。

調查範圍
調查年份 2022-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（百萬美元）
部分 按組件、產品類型、技術、應用、最終用戶、地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

按組成部分，腦機介面市場分為硬體和軟體。預計硬體產業在預測期內將呈現最高成長率。隨著公司和研究機構對硬體開發進行了大量投資，人們越來越關注頭戴式耳機和耳機等穿戴式 BCI 產品的採用，推動了這個市場的成長。

依產品類型，腦機介面市場分為非侵入式腦機介面、部分侵入式腦機介面和侵入式腦機介面。預計非侵入性腦機介面領域將在預測期內呈現最高成長率。由於消除了手術植入的需要以及最終用戶擴大採用該細分市場，預計該細分市場將出現顯著成長。

依技術分類，腦機介面市場分為腦電圖（EEG）、功能性磁振造影（fMRI）、腦磁圖（MEG）、皮質電圖（ECoG）和功能性近紅外線光光譜（fNIRS）等。預計腦電圖 (EEG) 領域在預測期內將呈現最高成長率。由於大量參與者參與腦電圖硬體的開發以及基於腦電圖的神經科學研究的發展，預計腦電圖的採用將會增加。

該報告研究了全球腦機介面市場，包括按組件、產品類型、技術、應用、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 市場動態
  • 產業動態
  • 價格分析
  • 價值鏈分析
  • 生態系分析
  • 波特五力分析
  • 主要相關人員和採購標準
  • 監管狀況
  • 技術分析
  • 專利分析
  • 贖回場景分析
  • 經營模式分析
  • 貿易分析
  • 案例研究分析
  • 2024-2025年主要會議和活動
  • 未滿足的需求和最終用戶的期望
  • 影響客戶業務的趨勢/干擾
  • 投資金籌措狀況

第6章腦機介面市場（依組成部分）

  • 介紹
  • 硬體
  • 軟體

第7章腦機介面市場，依產品類型

  • 介紹
  • 非侵入性腦機介面
  • 部分侵入式腦機介面
  • 侵入式腦機介面

第8章腦機介面市場（按技術）

  • 介紹
  • 腦電圖測試
  • 磁腦電圖
  • 皮層電記錄
  • 功能性磁振造影
  • 功能近紅外線光譜
  • 直接資料介面

第9章腦機介面市場，依應用分類

  • 介紹
  • 輔助技術
  • 殘疾和康復
  • 其他

第10章腦機介面市場，依最終用戶分類

  • 介紹
  • 醫院和診所
  • 復健中心
  • 居家照護
  • 其他

第11章腦機介面市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第12章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 評價及財務指標
  • 品牌/產品比較
  • 競爭場景

第13章 公司簡介

  • 主要參與企業
    • NEUROSKY
    • EMOTIV
    • ANT NEURO
    • G.TEC MEDICAL ENGINEERING GMBH
    • NEURABLE
    • ADVANCED BRAIN MONITORING, INC.
    • BRAIN PRODUCTS GMBH
    • CGX
    • RIPPLE NEURO
    • BITBRAIN TECHNOLOGIES
    • OPEN BCI
    • ARTINIS MEDICAL SYSTEMS
    • PARADROMICS
    • BRAINCO, INC.
    • MINDMAZE
    • COGNIXION
    • BLACKROCK NEUROTECH
    • CORTEC GMBH
    • INTERAXON, INC.
    • NEUROLUTIONS, INC.
  • 其他公司
    • CONSCIOUS LABS
    • KERNEL
    • AAVAA INC.
    • NEXSTEM
    • BIRGERMIND

第14章附錄

簡介目錄
Product Code: HIT 9020

The brain computer interface market is projected to reach USD 506 million by 2029 from USD 262 million in 2024, at a CAGR 14.1% during the forecast period. The growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable BCI devices, and rising investments in research and development, along with the increasing demand for non-invasive and wearable BCI devices are the factors that will drive the growth of this market. On the other hand, stringent regulatory requirements and high cost associated BCI systems may impede the adoption of brain computer interface solutions to a certain extent over the forecast period.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Million
SegmentsComponent, Product Type, Technology, Application, End User, and Region
Regions coveredNorth America, Europe, APAC, LATAM, MEA

"Hardware segment is expected to register highest growth in the forecast period, by component."

Based on component, the brain computer interface market is segmented into hardware and software. The hardware segment is projected to witness the highest growth rate during the forecast period. Growth in this market can be attributed to the growing focus on adopting wearable BCI products such as headsets, headphones and others in response to the significant investment in hardware development by companies and research institutions.

"Non-invasive brain computer interface segment is expected to register highest growth in the forecast period of brain computer interface market, by product type."

Based on product type, the brain computer interface market is segmented into non-invasive brain computer interface, partially invasive brain computer interface, and invasive brain computer interface. The non-invasive brain computer interface segment is projected to witness the highest growth rate during the forecast period. This segment is expected to witness significant growth due to eliminating the need for surgical implantation, and growing adoption of this segment among end users.

"The electroencephalography (EEG) segment is expected to register highest growth in the forecast period, by end user."

Based on technology, the brain computer interface market is segmented into Electroencephalography (EEG), Functional Magnetic Resonance Imaging (fMRI), Magnetoencephalography (MEG), Electrocorticography (ECoG), and Functional Near-Infrared Spectroscopy (fNIRS). The electroencephalography (EEG) segment is projected to witness the highest growth rate during the forecast period. The adoption of EEG is expected to increase due to the large number of players involved in developing EEG hardware, and growing EEG based neuroscience research.

"The disabilities restoration/ rehabilitation accounted for the largest share of the application segment of the brain computer interface market"

Based on application, the brain computer interface market is segmented into disabilities restoration/ rehabilitation, assistive technologies, and other applications. The increasing prevalence of neurological conditions like stroke, spinal cord injury, and amyotrophic lateral sclerosis (ALS) along with the growing healthcare spending and rising research and development initiatives is expected to fuel the demand for disabilities restoration/ rehabilitation solutions among end users.

"The rehabilitation centers segment is expected to register highest growth in the forecast period, by end user."

Based on end user, the brain computer interface market is segmented into hospitals & clinics, rehabilitation centers, homecare settings, and other end users. . The rehabilitation centers segment is projected to witness the highest growth rate during the forecast period. The growth of brain computer interface adoption among rehabilitation centers is driven by their commitment to leveraging technological advancements, lower costs, easy accessibility, and lower waiting times as compared to hospitals to improve patient outcomes.

"Asia Pacific to register the highest growth in the brain computer interface market in the forecast period."

The global brain computer interface market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and Middle East & Africa. In 2023, Asia Pacific was expected to register the highest growth for brain computer interface solutions in the forecast period. Factors such as the affordable labor and a skilled workforce, rising disposable incomes, increasing incidence of neurodegenerative disorders, and a growing governmental focus on healthcare reforms within the region are expected to drive the growth of the brain computer interface market in the Asia Pacific.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:

  • By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
  • By Designation: C-level Executives (27%), Director-level (18%), and Others (55%)
  • By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East and Africa (5%)

The prominent players in this market are Advanced Brain Monitoring, Inc. (US), Neurosky (US), Brain Products GmbH (Germany), CGX (US), Ripple Neuro (US), Neurable (US), InteraXon (US), Open BCI (US), Neurolutions, Inc. (US), ANT Neuro (Netherlands), Bitbrain (Spain), Kernel (US), Paradromics (US), BrainCo (US), Blackrock Neurotech (US), G.Tech Medical Engineering GmbH (Austria), Emotiv (US), BirgerMind (Latvia), Cognixion (US), Artinis Medical Systems (Netherlands), MindMaze (Switzerland), Cortec GmbH (Germany), AAVAA Inc. (Canada), Nexstem (India), and Conscious Labs (France). Players adopted organic as well as inorganic growth strategies such as new product launches, agreements, collaborations, and expansions to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

The report studies the brain computer interface market based on component, product type, technology, application, end user, and region. The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total brain computer interface market. The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

  • Analysis of key drivers (growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable BCI devices, rising investments in research and development), restraints (high cost of BCI devices, and stringent regulatory requirements), opportunities (growth opportunities in emerging markets, and growing applications of BCI technology) and challenge (shortage of trained medical professionals, and data security and privacy concerns)
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the brain computer interface market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of brain computer interface solutions across regions.
  • Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the brain computer interface market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the brain computer interface market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 BRAIN-COMPUTER INTERFACE MARKET SEGMENTATION
    • 1.3.2 REGIONS COVERED
    • FIGURE 2 BRAIN-COMPUTER INTERFACE MARKET: REGIONAL SEGMENTATION
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 RECESSION IMPACT: BRAIN-COMPUTER INTERFACE MARKET

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • FIGURE 3 RESEARCH APPROACH
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 7 TOP-DOWN APPROACH
    • FIGURE 8 BOTTOM-UP APPROACH
    • FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BRAIN-COMPUTER INTERFACE MARKET (2024-2029)
    • FIGURE 10 CAGR PROJECTIONS
  • 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: BRAIN-COMPUTER INTERFACE MARKET
  • 2.8 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 12 BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2024 VS. 2027 (USD MILLION)
    • FIGURE 15 BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2024 VS. 2027 (USD MILLION)
    • FIGURE 16 BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2024 VS. 2027 (USD MILLION)
    • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF BRAIN-COMPUTER INTERFACE MARKET

4 PREMIUM INSIGHTS

  • 4.1 BRAIN-COMPUTER INTERFACE MARKET OVERVIEW
    • FIGURE 18 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE AND COUNTRY (2023)
    • FIGURE 19 NON-INVASIVE BCI ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.3 BRAIN-COMPUTER INTERFACE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 BRAIN-COMPUTER INTERFACE MARKET, BY REGION 2023-2029
    • FIGURE 21 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
  • 4.5 BRAIN-COMPUTER INTERFACE MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES
    • FIGURE 22 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 23 BRAIN-COMPUTER INTERFACE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing incidence & prevalence of neurological disorders
      • 5.2.1.2 Increasing demand for non-invasive & wearable BCI devices
      • 5.2.1.3 Rising investment in R&D
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of BCI systems
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
    • FIGURE 24 GLOBAL HEALTHCARE EXPENDITURE SHARE, 1995 VS 2022
      • 5.2.3.2 Growing applications of BCI technology
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of trained medical professionals
      • 5.2.4.2 Data security & privacy concerns
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 FOCUS ON NON-INVASIVE BCIS
    • 5.3.2 INTEGRATION WITH WEARABLE TECHNOLOGY
  • 5.4 PRICING ANALYSIS
    • 5.4.1 AVERAGE SELLING PRICE TREND, BY HARDWARE
    • TABLE 2 AVERAGE SELLING PRICE OF BRAIN-COMPUTER INTERFACE, BY HARDWARE
    • 5.4.2 AVERAGE SELLING PRICE TREND OF BRAIN-COMPUTER INTERFACE, BY PRODUCT TYPE
    • TABLE 3 AVERAGE SELLING PRICE OF BRAIN-COMPUTER INTERFACE, BY PRODUCT TYPE
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 25 VALUE CHAIN ANALYSIS: BRAIN-COMPUTER INTERFACE MARKET
  • 5.6 ECOSYSTEM ANALYSIS
    • FIGURE 26 ECOSYSTEM ANALYSIS: KEY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 BRAIN-COMPUTER INTERFACE MARKET: PORTER'S FIVE FORCES
    • 5.7.1 BARGAINING POWER OF BUYERS
    • 5.7.2 BARGAINING POWER OF SUPPLIERS
    • 5.7.3 THREAT OF NEW ENTRANTS
    • 5.7.4 THREAT OF SUBSTITUTES
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • TABLE 5 LIST OF KEY STAKEHOLDERS AND THEIR ROLE
    • TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY COMPONENT
    • 5.8.2 BUYING CRITERIA
    • FIGURE 27 KEY BUYING CRITERIA FOR BRAIN-COMPUTER INTERFACE, BY COMPONENT
    • TABLE 7 KEY BUYING CRITERIA FOR BRAIN-COMPUTER INTERFACE, BY COMPONENT
  • 5.9 REGULATORY LANDSCAPE
    • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.9.2 REGULATORY ANALYSIS
      • 5.9.2.1 North America
        • 5.9.2.1.1 US
    • TABLE 11 US FDA: CLASSIFICATION OF MEDICAL DEVICES
    • TABLE 12 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.9.2.2 Europe
      • 5.9.2.3 Asia Pacific
        • 5.9.2.3.1 China
    • TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
        • 5.9.2.3.2 India
    • TABLE 14 INDIA: CLASSIFICATION OF NON-NOTIFIED MEDICAL DEVICES
      • 5.9.2.4 Latin America
        • 5.9.2.4.1 Brazil
      • 5.9.2.5 Middle East & Africa
        • 5.9.2.5.1 UAE
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 KEY TECHNOLOGIES
      • 5.10.1.1 Artificial Intelligence (AI) and Machine Learning (ML)
      • 5.10.1.2 Signal Processing
    • 5.10.2 COMPLEMENTARY TECHNOLOGIES
      • 5.10.2.1 Neuroimaging
      • 5.10.2.2 Wearable Technology
    • 5.10.3 ADJACENT TECHNOLOGIES
      • 5.10.3.1 Robotics & Prosthetics
      • 5.10.3.2 Virtual Reality (VR) & Augmented Reality (AR)
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS
    • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN-COMPUTER INTERFACE
    • FIGURE 28 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR BRAIN-COMPUTER INTERFACE PATENTS, 2013-2023
    • TABLE 15 NUMBER OF DOCUMENTS FOR BRAIN-COMPUTER INTERFACE PATENTS, 2013-2023
    • 5.11.3 PATENT APPLICATIONS AND OWNERS
    • FIGURE 29 MAJOR PATENTS FOR BRAIN-COMPUTER INTERFACE (2013-2023)
    • 5.11.4 LIST OF PATENTS/PATENT APPLICATIONS
    • TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS IN BRIAN COMPUTER INTERFACE MARKET, JANUARY 2021-MAY 2024
  • 5.12 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.13 BUSINESS MODEL ANALYSIS
  • 5.14 TRADE ANALYSIS
    • 5.14.1 TRADE ANALYSIS FOR BRAIN-COMPUTER INTERFACE MARKET
    • FIGURE 30 IMPORT DATA FOR BRAIN-COMPUTER INTERFACE MARKET (HS CODE 852692), BY COUNTRY, 2021-2023 (USD THOUSAND)
    • FIGURE 31 EXPORT DATA FOR BRAIN-COMPUTER INTERFACE MARKET (HS CODE 852692), BY COUNTRY, 2021-2023 (USD THOUSAND)
  • 5.15 CASE STUDY ANALYSIS
    • TABLE 17 CASE STUDY 1: EXPLORING USER-CENTERED DESIGN PERSPECTIVES IN BRAIN-COMPUTER INTERFACE RESEARCH
    • TABLE 18 CASE STUDY 2: ASSESSING THE INTEGRATION OF BRAIN-COMPUTER INTERFACE AND INTERNET OF THINGS FOR HEALTHCARE APPLICATIONS
  • 5.16 KEY CONFERENCES & EVENTS, 2024-2025
    • TABLE 19 LIST OF KEY CONFERENCES & EVENTS IN BRAIN-COMPUTER INTERFACE MARKET, JANUARY 2024-DECEMBER 2025
  • 5.17 UNMET NEEDS AND END-USER EXPECTATIONS
    • 5.17.1 UNMET NEEDS
    • TABLE 20 UNMET NEEDS IN BRAIN-COMPUTER INTERFACE MARKET
    • 5.17.2 END-USER EXPECTATIONS
    • TABLE 21 END-USER EXPECTATIONS IN BRAIN-COMPUTER INTERFACE MARKET
  • 5.18 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.19 INVESTMENT AND FUNDING LANDSCAPE
    • FIGURE 32 FUNDING IN BRAIN-COMPUTER INTERFACE MARKET, BY PLAYER

6 BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT

  • 6.1 INTRODUCTION
    • TABLE 22 BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • 6.2 HARDWARE
    • 6.2.1 ADVANCEMENTS IN HARDWARE AND INCREASING DEMAND FOR NON-INVASIVE BCI SOLUTIONS TO DRIVE MARKET GROWTH
    • TABLE 23 BRAIN-COMPUTER INTERFACE HARDWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3 SOFTWARE
    • 6.3.1 INCREASING ADOPTION OF TECHNOLOGICALLY ADVANCED BCI SOFTWARE SOLUTIONS TO FUEL MARKET GROWTH
    • TABLE 24 BRAIN-COMPUTER INTERFACE SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE

  • 7.1 INTRODUCTION
    • TABLE 25 BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
  • 7.2 NON-INVASIVE BRAIN-COMPUTER INTERFACES
    • 7.2.1 DEVELOPMENT OF ADVANCED EEG HEADSETS TO DRIVE ADOPTION
    • TABLE 26 NON-INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3 PARTIALLY INVASIVE BRAIN-COMPUTER INTERFACES
    • 7.3.1 TECHNOLOGICAL ADVANCEMENTS AND RISING NEUROLOGICAL DISORDER INCIDENCE TO DRIVE DEMAND
    • TABLE 27 PARTIALLY INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.4 INVASIVE BRAIN-COMPUTER INTERFACES
    • 7.4.1 GROWING R&D AND RISING INVESTMENTS TO FUEL MARKET GROWTH
    • TABLE 28 INVASIVE BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

8 BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 29 BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
  • 8.2 ELECTROENCEPHALOGRAPHY
    • 8.2.1 TECHNOLOGICAL ADVANCEMENTS TO BOOST MARKET GROWTH
    • TABLE 30 EEG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3 MAGNETOENCEPHALOGRAPHY
    • 8.3.1 HIGH COST OF MEG-BASED BCI SOLUTIONS TO LIMIT MARKET GROWTH
    • TABLE 31 MEG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.4 ELECTROCORTICOGRAPHY
    • 8.4.1 FOCUS ON ESTABLISHING FEASIBILITY & EFFICACY OF ECOG-BASED BCIS TO DRIVE MARKET
    • TABLE 32 ECOG-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.5 FUNCTIONAL MAGNETIC RESONANCE IMAGING
    • 8.5.1 LARGE SIZE AND HIGH PRICE OF FMRI SCANNERS TO LIMIT APPLICATIONS IN HOME CARE SETTINGS
    • TABLE 33 FMRI-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.6 FUNCTIONAL NEAR-INFRARED SPECTROSCOPY
    • 8.6.1 PORTABILITY, SAFETY, AND REAL-TIME BRAIN ACTIVITY MONITORING TO FUEL DEMAND
    • TABLE 34 FNIRS-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.7 DIRECT DATA INTERFACE
    • 8.7.1 HIGH COST AND LIMITED REIMBURSEMENT OPTIONS TO RESTRAIN GROWTH
    • TABLE 35 DDI-BASED BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

9 BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 36 BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • 9.2 ASSISTIVE TECHNOLOGIES
    • 9.2.1 DEVELOPMENT OF INNOVATIVE SOLUTIONS AND GROWING R&D TO BOOST ADOPTION OF BCI IN ASSISTIVE TECHNOLOGIES
    • TABLE 37 BRAIN-COMPUTER INTERFACE MARKET FOR ASSISTIVE TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.3 DISABILITIES & REHABILITATION
    • 9.3.1 RISING DEMAND FOR ADVANCED SOLUTIONS AND INCREASING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET
    • TABLE 38 BRAIN-COMPUTER INTERFACE MARKET FOR DISABILITIES & REHABILITATION, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.4 OTHER APPLICATIONS
    • TABLE 39 BRAIN-COMPUTER INTERFACE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)

10 BRAIN-COMPUTER INTERFACE MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 40 BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.2 HOSPITALS & CLINICS
    • 10.2.1 EARLY ADOPTION, WIDE APPLICATIONS, AND GROWING R&D TO SUPPORT MARKET GROWTH
    • TABLE 41 BRAIN-COMPUTER INTERFACE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 10.3 REHABILITATION CENTERS
    • 10.3.1 SHORTAGE OF TRAINED PROFESSIONALS TO CHALLENGE MARKET GROWTH
    • TABLE 42 BRAIN-COMPUTER INTERFACE MARKET FOR REHABILITATION CENTERS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 10.4 HOME CARE SETTINGS
    • 10.4.1 PREFERENCE FOR IN-HOME CARE AND GROWING AGING POPULATION TO DRIVE DEMAND
    • TABLE 43 BRAIN-COMPUTER INTERFACE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 10.5 OTHER END USERS
    • TABLE 44 BRAIN-COMPUTER INTERFACE MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)

11 BRAIN-COMPUTER INTERFACE MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 45 BRAIN-COMPUTER INTERFACE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 11.2 NORTH AMERICA
    • 11.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 33 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET SNAPSHOT
    • TABLE 46 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 47 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 48 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 49 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 50 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 51 NORTH AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.2.2 US
      • 11.2.2.1 US to dominate North American market
    • TABLE 52 US: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 53 US: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 54 US: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 55 US: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 56 US: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.2.3 CANADA
      • 11.2.3.1 Growing adoption and government support to propel market growth
    • TABLE 57 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 58 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 59 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 60 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 61 CANADA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.3 EUROPE
    • 11.3.1 EUROPE: RECESSION IMPACT
    • TABLE 62 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 63 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 64 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 65 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 66 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 67 EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.2 GERMANY
      • 11.3.2.1 Government support and demand for neurorehabilitation solutions to fuel market growth
    • TABLE 68 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 69 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 70 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 71 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 72 GERMANY: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.3 UK
      • 11.3.3.1 Rising prevalence of neurological disorders to drive market
    • TABLE 73 UK: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 74 UK: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 75 UK: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 76 UK: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 77 UK: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.4 FRANCE
      • 11.3.4.1 Rising geriatric population to increase demand for BCI solutions
    • TABLE 78 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 79 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 80 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 81 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 82 FRANCE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.5 ITALY
      • 11.3.5.1 Increasing initiatives to propel market growth
    • TABLE 83 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 84 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 85 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 86 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 87 ITALY: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.6 SPAIN
      • 11.3.6.1 Rising R&D and improving health spending to drive market
    • TABLE 88 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 89 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 90 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 91 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 92 SPAIN: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.3.7 REST OF EUROPE
    • TABLE 93 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 94 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 95 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 96 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 97 REST OF EUROPE: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • 11.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 34 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET SNAPSHOT
    • TABLE 98 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 100 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 102 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Growing demand for assistive technologies to fuel market growth
    • TABLE 104 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 105 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 106 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 107 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 108 JAPAN: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.3 CHINA
      • 11.4.3.1 Technological innovations to increase demand
    • TABLE 109 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 110 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 111 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 112 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 113 CHINA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.4 INDIA
      • 11.4.4.1 Increasing government initiatives to boost demand for BCI
    • TABLE 114 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 115 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 116 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 117 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 118 INDIA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.4.5 REST OF ASIA PACIFIC
    • TABLE 119 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 120 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 121 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 122 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 123 REST OF ASIA PACIFIC: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.5 LATIN AMERICA
    • 11.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 124 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 125 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 126 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 127 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 128 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 129 LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.5.2 BRAZIL
      • 11.5.2.1 High cost of BCI solutions to hamper market growth
    • TABLE 130 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 131 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 132 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 133 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 134 BRAZIL: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.5.3 MEXICO
      • 11.5.3.1 Initiatives for healthcare infrastructure development to support market growth
    • TABLE 135 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 136 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 137 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 138 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 139 MEXICO: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.5.4 REST OF LATIN AMERICA
    • TABLE 140 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 141 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 142 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 143 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 144 REST OF LATIN AMERICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 145 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 146 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 147 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 148 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 149 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 150 MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.6.2 GCC COUNTRIES
      • 11.6.2.1 Healthcare infrastructural development to drive demand for BCI solutions
    • TABLE 151 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 152 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 153 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 154 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 155 GCC COUNTRIES: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 11.6.3 REST OF MIDDLE EAST & AFRICA
    • TABLE 156 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
    • TABLE 157 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY PRODUCT TYPE, 2022-2029 (USD MILLION)
    • TABLE 158 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
    • TABLE 159 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
    • TABLE 160 REST OF MIDDLE EAST & AFRICA: BRAIN-COMPUTER INTERFACE MARKET, BY END USER, 2022-2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET
    • FIGURE 35 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
  • 12.3 MARKET SHARE ANALYSIS
    • FIGURE 36 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BRAIN-COMPUTER INTERFACE MARKET (2023)
    • TABLE 161 BRAIN-COMPUTER INTERFACE MARKET: DEGREE OF COMPETITION
  • 12.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.4.1 STARS
    • 12.4.2 PERVASIVE PLAYERS
    • 12.4.3 EMERGING LEADERS
    • 12.4.4 PARTICIPANTS
    • FIGURE 37 BRAIN-COMPUTER INTERFACE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 12.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.4.5.1 Company footprint
    • FIGURE 38 BRAIN-COMPUTER INTERFACE MARKET: COMPANY FOOTPRINT
      • 12.4.5.2 Component footprint
    • TABLE 162 BRAIN-COMPUTER INTERFACE MARKET: COMPONENT FOOTPRINT
      • 12.4.5.3 Product type footprint
    • TABLE 163 BRAIN-COMPUTER INTERFACE MARKET: PRODUCT TYPE FOOTPRINT
      • 12.4.5.4 Technology footprint
    • TABLE 164 BRAIN-COMPUTER INTERFACE MARKET: TECHNOLOGY FOOTPRINT
      • 12.4.5.5 Application footprint
    • TABLE 165 BRAIN-COMPUTER INTERFACE MARKET: APPLICATION FOOTPRINT
  • 12.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.5.1 PROGRESSIVE COMPANIES
    • 12.5.2 DYNAMIC COMPANIES
    • 12.5.3 STARTING BLOCKS
    • 12.5.4 RESPONSIVE COMPANIES
    • FIGURE 39 BRAIN-COMPUTER INTERFACE MARKET: COMPANY EVALUATION MATRIX (SMES/ STARTUPS), 2023
    • 12.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    • TABLE 166 BRAIN-COMPUTER INTERFACE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
    • TABLE 167 BRAIN-COMPUTER INTERFACE MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
  • 12.6 VALUATION AND FINANCIAL METRICS
    • FIGURE 40 EV/EBITDA OF KEY VENDORS
    • FIGURE 41 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • 12.7 BRAND/PRODUCT COMPARISON
    • FIGURE 42 BRAIN-COMPUTER INTERFACE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 12.8 COMPETITIVE SCENARIO
    • 12.8.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 168 BRAIN-COMPUTER INTERFACE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-MAY 2024
    • 12.8.2 DEALS
    • TABLE 169 BRAIN-COMPUTER INTERFACE MARKET: DEALS, JANUARY 2021-MAY 2024
    • 12.8.3 EXPANSIONS
    • TABLE 170 BRAIN-COMPUTER INTERFACE MARKET: EXPANSIONS, JANUARY 2021-MAY 2024

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 13.1.1 NEUROSKY
    • TABLE 171 NEUROSKY: COMPANY OVERVIEW
    • TABLE 172 NEUROSKY: PRODUCTS OFFERED
    • 13.1.2 EMOTIV
    • TABLE 173 EMOTIV: COMPANY OVERVIEW
    • TABLE 174 EMOTIV: PRODUCTS OFFERED
    • 13.1.3 ANT NEURO
    • TABLE 175 ANT NEURO: COMPANY OVERVIEW
    • TABLE 176 ANT NEURO: PRODUCTS OFFERED
    • TABLE 177 ANT NEURO: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021-MAY 2024)
    • TABLE 178 ANT NEURO: EXPANSIONS (JANUARY 2021-MAY 2024)
    • 13.1.4 G.TEC MEDICAL ENGINEERING GMBH
    • TABLE 179 G.TEC MEDICAL ENGINEERING GMBH: COMPANY OVERVIEW
    • TABLE 180 G.TEC MEDICAL ENGINEERING GMBH: PRODUCTS OFFERED
    • 13.1.5 NEURABLE
    • TABLE 181 NEURABLE: COMPANY OVERVIEW
    • TABLE 182 NEURABLE: PRODUCTS OFFERED
    • TABLE 183 NEURABLE: DEALS (JANUARY 2021-MAY 2024)
    • 13.1.6 ADVANCED BRAIN MONITORING, INC.
    • TABLE 184 ADVANCED BRAIN MONITORING, INC.: COMPANY OVERVIEW
    • TABLE 185 ADVANCED BRAIN MONITORING, INC.: PRODUCTS OFFERED
    • 13.1.7 BRAIN PRODUCTS GMBH
    • TABLE 186 BRAIN PRODUCTS GMBH: COMPANY OVERVIEW
    • TABLE 187 BRAIN PRODUCTS GMBH: PRODUCTS OFFERED
    • 13.1.8 CGX
    • TABLE 188 CGX: COMPANY OVERVIEW
    • TABLE 189 CGX: PRODUCTS OFFERED
    • TABLE 190 CGX: EXPANSIONS (JANUARY 2021-MAY 2024)
    • 13.1.9 RIPPLE NEURO
    • TABLE 191 RIPPLE NEURO: COMPANY OVERVIEW
    • TABLE 192 RIPPLE NEURO: PRODUCTS OFFERED
    • 13.1.10 BITBRAIN TECHNOLOGIES
    • TABLE 193 BITBRAIN TECHNOLOGIES: COMPANY OVERVIEW
    • TABLE 194 BITBRAIN TECHNOLOGIES: PRODUCTS OFFERED
    • 13.1.11 OPEN BCI
    • TABLE 195 OPENBCI: COMPANY OVERVIEW
    • TABLE 196 OPENBCI: PRODUCTS OFFERED
    • 13.1.12 ARTINIS MEDICAL SYSTEMS
    • TABLE 197 ARTINIS MEDICAL SYSTEMS: COMPANY OVERVIEW
    • TABLE 198 ARTINIS MEDICAL SYSTEMS: PRODUCTS OFFERED
    • 13.1.13 PARADROMICS
    • TABLE 199 PARADROMICS: COMPANY OVERVIEW
    • TABLE 200 PARADROMICS: PRODUCTS OFFERED
    • TABLE 201 PARADROMICS: PRODUCT APPROVALS (JANUARY 2021-MAY 2024)
    • 13.1.14 BRAINCO, INC.
    • TABLE 202 BRAINCO, INC.: COMPANY OVERVIEW
    • TABLE 203 BRAINCO, INC.: PRODUCTS OFFERED
    • 13.1.15 MINDMAZE
    • TABLE 204 MINDMAZE: COMPANY OVERVIEW
    • TABLE 205 MINDMAZE: PRODUCTS OFFERED
    • TABLE 206 MINDMAZE: PRODUCT LAUNCHES & APPROVALS (JANUARY 2021-MAY 2024)
    • TABLE 207 MINDMAZE: DEALS (JANUARY 2021-MAY 2024)
    • 13.1.16 COGNIXION
    • TABLE 208 COGNIXION: COMPANY OVERVIEW
    • TABLE 209 COGNIXION: PRODUCTS OFFERED
    • TABLE 210 COGNIXION: PRODUCT APPROVALS (JANUARY 2021-MAY 2024)
    • 13.1.17 BLACKROCK NEUROTECH
    • TABLE 211 BLACKROCK NEUROTECH: COMPANY OVERVIEW
    • TABLE 212 BLACKROCK NEUROTECH: PRODUCTS OFFERED
    • TABLE 213 BLACKROCK NEUROTECH: PRODUCT LAUNCHES (JANUARY 2021-MAY 2024)
    • 13.1.18 CORTEC GMBH
    • TABLE 214 CORTEC GMBH: COMPANY OVERVIEW
    • TABLE 215 CORTEC GMBH: PRODUCTS OFFERED
    • 13.1.19 INTERAXON, INC.
    • TABLE 216 INTERAXON, INC.: COMPANY OVERVIEW
    • TABLE 217 INTERAXON, INC.: PRODUCTS OFFERED
    • 13.1.20 NEUROLUTIONS, INC.
    • TABLE 218 NEUROLUTIONS, INC.: COMPANY OVERVIEW
    • TABLE 219 NEUROLUTIONS, INC.: PRODUCTS OFFERED
    • TABLE 220 NEUROLUTIONS: PRODUCT APPROVALS (JANUARY 2021-MAY 2024)
  • 13.2 OTHER PLAYERS
    • 13.2.1 CONSCIOUS LABS
    • TABLE 221 CONSCIOUS LABS: COMPANY OVERVIEW
    • TABLE 222 CONSCIOUS LABS: PRODUCTS OFFERED
    • 13.2.2 KERNEL
    • TABLE 223 KERNEL: COMPANY OVERVIEW
    • TABLE 224 KERNEL: PRODUCTS OFFERED
    • TABLE 225 KERNEL: PRODUCT LAUNCHES (JANUARY 2021-MAY 2024)
    • 13.2.3 AAVAA INC.
    • TABLE 226 AAVAA INC.: COMPANY OVERVIEW
    • TABLE 227 AAVAA INC.: PRODUCTS OFFERED
    • TABLE 228 AAVAA: PRODUCT LAUNCHES (JANUARY 2021-MAY 2024)
    • 13.2.4 NEXSTEM
    • TABLE 229 NEXSTEM: COMPANY OVERVIEW
    • TABLE 230 NEXSTEM: PRODUCTS OFFERED
    • 13.2.5 BIRGERMIND
    • TABLE 231 BIRGERMIND: COMPANY OVERVIEW
    • TABLE 232 BIRGERMIND: PRODUCTS OFFERED
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS